Skip to main content
Clinical Trials/NCT02515019
NCT02515019
Completed
Not Applicable

Bispectral Index Guided Titration of Sevoflurane in On-pump Cardiac Surgery Reduces Plasma Sevoflurane Concentration and Vasopressor Requirements

Universitätsklinikum Hamburg-Eppendorf1 site in 1 country60 target enrollmentApril 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intraoperative Hypotension
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Enrollment
60
Locations
1
Primary Endpoint
Cumulative intraoperative administration of norepinephrine
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Electroencephalographic-based monitoring systems such as the bispectral index (BIS) may reduce anaesthetic overdose rates. The investigators hypothesised that goal-directed sevoflurane administration (guided by BIS monitoring) could reduce the sevoflurane plasma concentration (SPC) and intraoperative vasopressor doses during on-pump cardiac surgery in a prospective, controlled, sequential two-arm clinical study.

Detailed Description

Electroencephalographic (EEG)-based monitoring systems, for example the bispectral index \[(BIS); BIS monitor, Covidien, Boulder, Colorado, USA\], were designed to prevent anaesthesia underdosage with the risk of awareness and to reduce the time to awakening after terminating general anaesthesia. However, little is known about the consequences of anaesthetic overdose. The investigators assume that high doses of anaesthetics result in cardiocirculatory depression and the necessity for high-dose vasopressor therapy, followed by microcirculation disorder and organ dysfunction. The investigators hypothesised that in on-pump cardiac-surgery, goaldirected administration of sevoflurane guided by BIS monitoring reduces excessive sevoflurane plasma concentration (SPC) and the need for an intraoperative vasopressor. To test this hypothesis, the current study compared BIS-guided sevoflurane administration with the constant delivery of an inspired sevoflurane concentration of 1.8% during on-pump cardiac surgery and analysed its effect on the SPC and the required intraoperative dosage of norepinephrine. The study population was divided into two patient groups: Thirty-three on-pump cardiac surgery patients enrolled in the study were allocated to a conventionally treated control group, with the constant administration of an inspired concentration of sevoflurane 1.8% (group Sevo1.8%). Thirty-four patients were sequentially allocated to an interventional group with BIS-guided administration of sevoflurane (group SevoBIS). Vasoactive drugs were administered according to the following protocol in both groups. If the mean arterial blood pressure decreased below 50 mmHg, a continuous infusion of norepinephrine was given to maintain a perfusion pressure between 50 and 60 mmHg during cardiopulmonary bypass. If the mean arterial pressure increased above 75 mmHg, nitroglycerine was used in boluses of 0.1 mg until arterial pressure returned to a mean of less than 75 mmHg. If mean arterial pressure persisted above 75 mmHg after a cumulative administration of nitroglycerine 1.0 mg, urapidil was administered in boluses of 0.1 mg/kg until the perfusion pressure decreased below 75 mmHg. At the end of the surgical procedure, all patients were transferred to the ICU.

Registry
clinicaltrials.gov
Start Date
April 2011
End Date
January 2012
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. med. Rainer Nitzschke

Dr. Rainer Nitzschke

Universitätsklinikum Hamburg-Eppendorf

Eligibility Criteria

Inclusion Criteria

  • Undergoing elective on-pump cardiac surgery and an American Society of Anesthesiologists' (ASA) physical status of 3 to 4

Exclusion Criteria

  • A contraindication to the administration of volatile anaesthetics, an active infection with a temperature more than 38°C and any history of neurological disease

Outcomes

Primary Outcomes

Cumulative intraoperative administration of norepinephrine

Time Frame: During operation

Secondary Outcomes

  • Incidence of acute kidney injury(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks)
  • Postoperative blood lactate concentration(Upon arrival in the intensive care unit (ICU))
  • ICU length of stay(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks)
  • Sevoflurane concentration in the oxygenator freshgas supply during cardiopulmonary bypass(During operation)
  • Duration of postoperative mechanical ventilation(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks)
  • Sevoflurane Plasma Concentration during CPB(During operation)

Study Sites (1)

Loading locations...

Similar Trials